Sinha S, Dua V K, Sharma V P
Indian J Malariol. 1989 Jun;26(2):83-6.
Studies on 725 P. vivax infected patients at the Bharat Heavy Electricals Ltd. produced 6.9 per cent relapse rate after administration of radical treatment of primaquine / 15 mg daily for 5 days as followed under the National Malaria Eradication Programme. Maximum relapses were recorded in a female patient in spite of repeated radical treatment.
对巴拉特重型电气有限公司的725名间日疟原虫感染患者进行的研究发现,按照国家疟疾根除计划,每日服用15毫克伯氨喹进行5天根治治疗后,复发率为6.9%。尽管进行了多次根治治疗,但一名女性患者的复发次数最多。